Skip to main content
NIH funding notice RFA-CA-15-005

Advanced Development and Validation of Emerging Technologies for Cancer-Relevant Biospecimen Science (R33)

Closed on September 22, 2015.

Posted
January 8, 2015
Close date
September 22, 2015
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,161,784 in first-year total cost, median $385,820.

Most frequent study sections

  1. Special Emphasis Panel[ZCA1 TCRB-W (O3)]2
  2. Special Emphasis Panel[ZCA1 TCRB-Q (J2)]1

Most frequent institutions

  1. UNIV OF ARKANSAS FOR MED SCIS1
  2. UNIVERSITY OF MINNESOTA1
  3. WAKE FOREST UNIVERSITY HEALTH SCIENCES1
Competing awards under RFA-CA-15-005 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2016Development and Validation of a Microdissection Method to Advance Precision Medicine in the Clinical Setting1R33CA202811-01JOHANN, DONALDTANGREA, MICHAELUNIV OF ARKANSAS FOR MED SCIS, AR$410,700ZCA1
2016Bioengineered Lung Tumor Organoids For Development Of Personalized Medicine1R33CA202822-01SOKER, SHAYWAKE FOREST UNIVERSITY HEALTH SCIENCES, NC$385,820ZCA1
2016Validation of a Room-Temperature Storage Technique for Plasma/Serum Biospecimens1R33CA204510-01AKSAN, ALPTEKINUNIVERSITY OF MINNESOTA, MN$365,264ZCA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-CA-15-005: Advanced Development and Validation of Emerging Technologies for Cancer-Relevant Biospecimen Science (R33) | ScienceDex | ConductScience